Skip to main content

Advertisement

SpringerLink
Log in

Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Introduction/Objectives

Pyoderma gangrenosum (PG) is a rare, rapidly progressive neutrophilic dermatosis commonly associated with systemic inflammatory diseases. We aimed to characterize the association of PG and inflammatory arthritis, as little is known outside of case reports and small cohort studies.

Method

We performed a systematic review in PubMed, EMBASE, and Scopus from inception to present using the terms arthritis and pyoderma gangrenosum. Patient demographics, clinical presentation, and treatment outcomes were recorded. Descriptive statistics and stratified analysis were used to compare factors of interest by type of arthritis.

Results

A total of 1399 articles were screened, and 129 patients with inflammatory arthritis and PG were included in the review. The most common types of arthritis were rheumatoid arthritis (RA) (50.4%), inflammatory bowel disease (IBD)–associated arthritis (10.9%), and psoriatic arthritis (8.5%). In the vast majority of cases, joint symptoms preceded PG, by a median of 10 years (inter-quartile range [IQR] 5–16). Corticosteroid monotherapy and biologic therapies, used alone or in combination, resulted in improvement or complete resolution of ulcers 71.4% and 67.3% of the time, respectively. Within the latter, infliximab, adalimumab, and anakinra were most successful in inducing remission overall. RA and non-RA did not differ significantly in treatment success or healing time.

Conclusions

This study shows that PG is frequently preceded by inflammatory arthritis, most commonly RA. Clinicians used a wide variety of treatment regimens with variable outcomes. While larger studies are needed to standardize the treatment of inflammatory arthritis-associated PG, this study suggests that in addition to systemic corticosteroids, biologic medications can be effective treatment options for these patients.

Key Points.

• Inflammatory arthritis, most commonly rheumatoid arthritis, often precedes rather than follows pyoderma gangrenosum.

• Other forms of arthritis associated with PG included IBD-associated arthritis and psoriatic arthritis.

• Biologic therapies, such as infliximab, adalimumab, and anakinra, were largely successful in treating arthritis-associated pyoderma gangrenosum and may play an important role in corticosteroid-sparing therapy or in a maintenance regimen for this subset of patients.

• The type of inflammatory arthritis associated with pyoderma gangrenosum may not be a helpful treatment guide as it was not significantly associated with treatment outcomes or healing time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Data availability

Available.

References

  1. Binus AM, Qureshi AA, Li VW, Winterfield LS (2011) Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patients. Br J Dermatol 165(6):1244–1250. https://doi.org/10.1111/j.1365-2133.2011.10565.x

    Article  CAS  PubMed  Google Scholar 

  2. Marzano AV, Cugno M, Trevisan V et al (2010) Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162(1):100–107. https://doi.org/10.1111/j.1365-2249.2010.04201.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Teagle A, Hargest R (2014) Management of pyoderma gangrenosum. J R Soc Med 107(6):228–236. https://doi.org/10.1177/0141076814534407

    Article  PubMed  PubMed Central  Google Scholar 

  4. Borda LJ, Wong LL, Marzano AV, Ortega-Loayza AG (2019) Extracutaneous involvement of pyoderma gangrenosum. Arch Dermatol Res 311(6):425–434. https://doi.org/10.1007/s00403-019-01912-1

    Article  PubMed  Google Scholar 

  5. Kridin K, Cohen AD, Amber KT (2018) Underlying systemic diseases in pyoderma gangrenosum: a systematic review and meta-analysis. Am J Clin Dermatol 19(4):479–487. https://doi.org/10.1007/s40257-018-0356-7

    Article  PubMed  Google Scholar 

  6. Kridin K, Damiani G, Cohen AD (2021) Rheumatoid arthritis and pyoderma gangrenosum: a population-based case-control study. Clin Rheumatol 40(2):521–528. https://doi.org/10.1007/s10067-020-05253-7

    Article  PubMed  Google Scholar 

  7. Vavricka SR, Brun L, Ballabeni P, Pittet V, PrinzVavricka BM, Zeitz J, Rogler G, Schoepfer AM (2011) Frequency and risk factors for extraintestinal manifestations in the Swiss inflammatory bowel disease cohort. Am J Gastroenterol 106(1):110–119. https://doi.org/10.1038/ajg.2010.343

    Article  PubMed  Google Scholar 

  8. Ashchyan HJ, Butler DC, Nelson CA et al (2018) JAMA dermatology original investigation the association of age with clinical presentation and comorbidities of pyoderma gangrenosum. JAMA Dermatol 154(4):409–413. https://doi.org/10.1001/jamadermatol.2017.5978

    Article  PubMed  PubMed Central  Google Scholar 

  9. Reichrath J, Bens G, Bonowitz A, Tilgen W (2005) Treatment recommendations for pyoderma gangrenosum: an evidence-based review of the literature based on more than 350 patients. J Am Acad Dermatol 53(2):273–283. https://doi.org/10.1016/j.jaad.2004.10.006

    Article  PubMed  Google Scholar 

  10. Charles CA, Bialy TL, Falabella AF, Eaglstein WH, Kerdel FA, Kirsner RS (2004) Poor prognosis of arthritis-associated pyoderma gangrenosum. Arch Dermatol 140(7):861–864. https://doi.org/10.1001/archderm.140.7.861

    Article  PubMed  Google Scholar 

  11. Ahronowitz I, Harp J, Shinkai K (2012) Etiology and management of pyoderma gangrenosum: a comprehensive review. Am J Clin Dermatol 13(3):191–211. https://doi.org/10.2340/00015555-2008

    Article  PubMed  Google Scholar 

  12. Bhat RM, Nandakishore B, Sequeira FF et al (2011) Pyoderma gangrenosum: an Indian perspective. Clin Exp Dermatol 36(3):242–247. https://doi.org/10.1111/j.1365-2230.2010.03941.x

    Article  CAS  PubMed  Google Scholar 

  13. Holt PJ, Davies MG, Saunder KC, Nuki G (1980) Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis. Medicine (Baltimore) 59(2):114–133

    Article  CAS  Google Scholar 

  14. Powell FC, Schroeter AL, Su WP, Perry HO (1985) Pyoderma gangrenosum: a review of 86 patients. Q J Med 55(217):173–186

    CAS  PubMed  Google Scholar 

  15. Langan SM, Groves RW, Card TR, Gulliford MC (2012) Incidence, mortality, and disease associations of pyoderma gangrenosum in the United Kingdom: a retrospective cohort study. J Invest Dermatol 132(9):2166–2170. https://doi.org/10.1038/jid.2012.130

    Article  CAS  PubMed  Google Scholar 

  16. Sayah A, English JC (2005) Rheumatoid arthritis: a review of the cutaneous manifestations. J Am Acad Dermatol 53(2):191–209. https://doi.org/10.1016/j.jaad.2004.07.023

    Article  PubMed  Google Scholar 

  17. Gupta AS, Ortega-Loayza AG (2019) Pyoderma gangrenosum: a too often overlooked facultative paraneoplastic disease. Ann Hematol 98(9):2247–2248. https://doi.org/10.1007/s00277-019-03732-9

    Article  PubMed  Google Scholar 

  18. Von den Driesch P (1997) Pyoderma gangrenosum: a report of 44 cases with follow-up. Br J Dermatol 137(6):1000–1005

    Article  Google Scholar 

  19. Ormerod AD, Thomas KS, Craig FE et al (2015) Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ 350:h2958. https://doi.org/10.1136/bmj.h2958

    Article  PubMed  PubMed Central  Google Scholar 

  20. Maalouf D, Battistella M, Bouaziz JD (2015) Neutrophilic dermatosis: disease mechanism and treatment. Curr Opin Hematol 22(1):23–29. https://doi.org/10.1097/MOH.0000000000000100

    Article  CAS  PubMed  Google Scholar 

  21. Brooklyn TN, Dunnill MGS, Shetty A et al (2006) Infliximab for the treatment of pyoderma gangrenosum: a randomised, double blind, placebo controlled trial. Gut 55(4):505–509. https://doi.org/10.1136/gut.2005.074815

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  22. Marzano AV, Fanoni D, Antiga E et al (2014) Expression of cytokines, chemokines and other effector molecules in two prototypic autoinflammatory skin diseases, pyoderma gangrenosum and sweet’s syndrome. Clin Exp Immunol 178(1):48–56. https://doi.org/10.1111/cei.12394

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. Wollina U, Tchernev G (2014) Pyoderma gangrenosum: pathogenetic oriented treatment approaches. Wien Med Wochenschr 164(13–14):263–273. https://doi.org/10.1007/s10354-014-0285-x

    Article  PubMed  Google Scholar 

  24. Cugno M, Gualtierotti R, Meroni PL, Marzano AV (2018) Inflammatory joint disorders and neutrophilic dermatoses: a comprehensive review. Clin Rev Allergy Immunol 54(2):269–281. https://doi.org/10.1007/s12016-017-8629-0

    Article  CAS  PubMed  Google Scholar 

Download references

Funding

Dr. Marcia Friedman.

3T32HL094294-08S1

KL2TR002370

DoM Wheels Up Early Physician Scientist Career Development Program.

Author information

Authors and Affiliations

  1. Department of Dermatology, Oregon Health & Science University, Center for Health and Healing, 3303 SW Bond Ave, Portland, OR, 97239, USA

    Erika Sawka, Allison Zhou & Alex G. Ortega-Loayza

  2. Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA

    Emile Latour

  3. Division of Rheumatology, Oregon Health & Science University, Portland, OR, USA

    Marcia Friedman

Authors
  1. Erika Sawka
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Allison Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Emile Latour
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Marcia Friedman
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alex G. Ortega-Loayza
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Alex G. Ortega-Loayza.

Ethics declarations

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sawka, E., Zhou, A., Latour, E. et al. Inflammatory arthritis-associated pyoderma gangrenosum: a systematic review. Clin Rheumatol 40, 3963–3969 (2021). https://doi.org/10.1007/s10067-021-05768-7

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-021-05768-7

Keywords

Search

Navigation